NCT01634555 2019-02-26A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRIEli Lilly and CompanyPhase 2 Completed29 enrolled 12 charts
NCT01463982 2015-04-23Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid MalignanciesHanmi Pharmaceutical Company LimitedPhase 1 Completed21 enrolled 10 charts